Results 91 to 100 of about 9,528 (197)
© The Author(s) 2019. Transcatheter technology has revolutionized the treatment of valvular disease in the field of cardiology and cardiac surgery. We present an interesting case of a patient with prior double valve replacements, which had degenerated ...
Nagy, Christian D +7 more
core +1 more source
Recurrent tricuspid regurgitation after failed ring annuloplasty is associated with high mortality rates and unfavourable clinical outcomes. Transcatheter tricuspid valve‐in‐ring (TVIR) replacement offers an alternative to high‐risk surgical reoperation,
Yiwei Wang, Yang Liu, Jian Yang
doaj +1 more source
A 41-year-old woman with history of situs inversus totalis, dextrocardia, congenitally corrected transposition of the great arteries, and systemic tricuspid valve replacement presented with worsening of her baseline orthopnea and exertional dyspnea ...
Lam, Wilson W +3 more
core +1 more source
Patient Selection for Transcatheter Tricuspid Valve Intervention: Not Too Early, Not Too Late
Tricuspid regurgitation (TR) is a common but frequently underrecognized condition associated with substantial morbidity and mortality. Long regarded as a mere bystander of left-sided heart disease, TR was often left untreated, contributing to late ...
Jennifer von Stein, MD +6 more
doaj +1 more source
Anaesthesia for transvenous transcatheter tricuspid valve-in-valve implantation
The authors report and discuss the anaesthetic management of a transvenous transcatheter tricuspid valve replacement. The conduct of anaesthesia, the challenges encountered and the specific risks associated with the procedure will be discussed ...
Coetzee, AR, Le Roux, P, Du Preez, LJ
core
International audienceIn patients with congenital heart diseases, new procedures, such as transcatheter valve replacement, have been associated with a non-negligible incidence of infective endocarditis (IE): up to 4% patient-year IE incidence. Prosthetic
Werner, O., Gavotto, A., Amedro, P.
core +1 more source
The emergence of percutaneous treatment options provides novel therapeutic alternatives for older and feeble patients who are at high risk for any surgical procedure.
Nikolaos Ktenopoulos +8 more
doaj +1 more source
A 49-year-old woman with a congenital quadricuspid aortic valve presented in cardiogenic shock due to severe aortic regurgitation. She underwent transfemoral transcatheter aortic valve replacement with a 29 mm self-expanding prosthesis. The procedure was
Abdullah Aljudaibi +2 more
doaj +1 more source
BACKGROUND Transcatheter tricuspid valve replacement (TTVR) abolishes tricuspid regurgitation (TR) and has emerged as a definitive treatment for TR.
Latib, Azeem +19 more
core +1 more source

